Galectin Therapeutics Inc (GALT) Insider Trading
- $20,784,867.70
- $17,753,147.64
- April 30, 2024
- Kevin D Freeman
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| May 28, 2013 | Director | 1,000 | $4.21 | Buy | $4,210.00 | |
| Oct. 12, 2012 | CEO | 2,500 | $2.11 | Buy | $5,275.00 | |
| Oct. 9, 2012 | CEO | 2,500 | $2.00 | Buy | $5,000.00 | |
| Oct. 8, 2012 | CEO | 5,000 | $2.07 | Buy | $10,350.00 |
Insiders are both buying and selling Galectin Therapeutics Inc stock.
The insider traders at Galectin Therapeutics Inc are: Kevin D Freeman, Fund L.P. 10X, Peter G Traber, Jack W Callicutt, James C Czirr, Marc Rubin, Kary Eldred, Harold H Shlevin, Richard A Jr. Zordani, Joel Lewis, Richard E Uihlein, Arthur Greenberg, Theodore Daniel Zucconi, Gilbert F Amelio, Gilbert S Omenn, John F Mauldin, Steven Prelack, and Elissa J Schwartz
The most active insider trader at Galectin Therapeutics Inc is Kevin D Freeman with 21 trades.
James C Czirr has sold the most Galectin Therapeutics Inc stock with a total value of $5,546,368.61.
Richard E Uihlein has bought the most Galectin Therapeutics Inc stock with a total value of $40,416,566.36.
The most recent insider trade for Galectin Therapeutics Inc was on April 30, 2024.
The single biggest insider buy for Galectin Therapeutics Inc was from Richard E Uihlein with a total value of $20,032,993.68 on May 31, 2019.
The single biggest insider sell for Galectin Therapeutics Inc was from Jack W Callicutt with a total value of $1,945,860.00 on June 20, 2018.